Evaluation of Concomitant Systemic Treatment in Older Adults With ...

In this cohort study of older adults with LA- HNSCC, chemoradiation, but not cetuximab-based bioradiotherapy, was associated with longer survival compared with ...

The results of this analysis suggest that older patients with locoregionally advanced head and neck squamous cell carcinoma may benefit from the addition of ...

Evaluation of Concomitant Systemic Treatment in Older Adults With ...

Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer.

Evaluation of Concomitant Systemic Treatment in Older Adults With ...

Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy · Abstract.

Evaluation of Concomitant Systemic Treatment in Older Adults With ...

Conclusions and Relevance: In this cohort study of older adults with LA- HNSCC, chemoradiation, but not cetuximab-based bioradiotherapy, was ...

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

Concomitant chemotherapy significantly improves survival in patients with HNSCC compared with definitive radiation therapy alone, as reported in ...

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

A Rühle, S Marschner, M Haderlein, et al. Evaluation of concomitant systemic treatment in older adults with head and neck squamous cell carcinoma undergoing ...

A Multicenter Evaluation of Different Chemotherapy Regimens in ...

Evaluation of concomitant systemic treatment in older adults with head and neck squamous cell · carcinoma undergoing definitive radiotherapy. JAMA Network ...

The toxicity and efficacy of concomitant chemoradiotherapy in ...

... therapy among older adults with ... Receipt of systemic therapy was dichotomized into patients receiving at least 6 weeks of treatment ...

Older adults with cancer and common comorbidities—challenges ...

Geriatric assessment is recommended for all older adults aged 65 years and older starting new treatment per ASCO guidelines supported by ...

The toxicity and efficacy of concomitant chemoradiotherapy in ...

multimodality therapy among older adults with OPSCC persists even in ... stratified by type of systemic therapy received in patients ...

Survival outcomes with concomitant chemoradiotherapy in older ...

Unplanned secondary analysis of clinical trials have shown no improvement in survival with either chemotherapy or cetuximab in older patients [6], [7], ...

Preliminary secondary analyses from the Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer trial ...

Anticancer drugs are not well tolerated in all older patients with cancer

To increase evidence for the treatment of older patients, trial designs could be adapted to ensure inclusion of older frail patients. Standard treatments ( ...

Radiotherapy for geriatric head-and-neck cancer patients

Concomitant systemic treatment was administered in 147 patients ... Treatment of older patients with head and neck cancer: a review.

Treatment of Elderly Patients with Squamous Cell Carcinoma of the ...

Results from a randomized trial conducted in lung cancer showed that treatment selection based on a comprehensive geriatric assessment (CGA) significantly ...

Head and Neck Squamous Cell Carcinoma in Elderly Patients - MDPI

The elderly population is often undertreated, as age is an independent risk factor for less intense and lower than average treatment rates [22] even though it ...

Non-Small Cell Lung Cancer Treatment (PDQ®) - NCI

... age group, although patients older than 65 years received less treatment. ... patients with non-small-cell lung cancer: a systematic review.

Addressing the quality of life needs of older patients with cancer

... patients' voices when evaluating the toxicities of oncologic treatments is well ... Systematic geriatric screening and assessment of older cancer patients ...

Initial treatment of elderly population with aggressive lymphoma

For extremely elderly and frail patients, who cannot tolerate curative intent therapy, the lack of application of universal assessment tools in ...